SecSonar.com

OptimizeRx Corporation (OPRX)

OptimizeRx Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

OptimizeRx Corporation (OPRX) is a Medical - Healthcare Information Services company based in US with a market capitalization of $98.8M. Revenue grew 18.8% year-over-year and the company generated $18.7M in free cash flow. This page tracks OPRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 128 employees · IPO Nov 28, 2007

Valuation

Valuation & price

$5.21 · as of May 17, 2026 · -76.0% vs 52w high

19.3

P/E ratio

Latest-FY diluted EPS

0.77

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.88$12.78$4.68Jul 25Dec 25Jul 26Jul 7, 25$13.05Jul 9, 25$13.54Jul 11, 25$12.70Jul 15, 25$12.97Jul 17, 25$13.99Jul 21, 25$12.88Jul 23, 25$13.77Jul 25, 25$14.35Jul 29, 25$12.89Jul 31, 25$12.62Aug 4, 25$12.86Aug 6, 25$12.48Aug 11, 25$16.18Aug 13, 25$17.33Aug 15, 25$16.86Aug 19, 25$15.80Aug 21, 25$16.14Aug 25, 25$17.00Aug 27, 25$17.53Aug 29, 25$18.07Sep 3, 25$17.54Sep 5, 25$18.82Sep 9, 25$17.79Sep 11, 25$18.83Sep 16, 25$18.12Sep 18, 25$18.92Sep 22, 25$19.09Sep 24, 25$18.41Sep 26, 25$18.78Sep 30, 25$20.50Oct 2, 25$17.60Oct 6, 25$17.68Oct 8, 25$18.24Oct 10, 25$18.08Oct 14, 25$19.90Oct 16, 25$19.78Oct 21, 25$19.84Oct 23, 25$19.59Oct 27, 25$20.88Oct 29, 25$20.56Oct 31, 25$20.49Nov 4, 25$18.78Nov 6, 25$18.94Nov 10, 25$16.51Nov 12, 25$16.15Nov 14, 25$15.18Nov 18, 25$14.12Nov 20, 25$13.58Nov 25, 25$15.39Nov 28, 25$15.27Dec 2, 25$14.11Dec 4, 25$14.65Dec 8, 25$14.01Dec 10, 25$13.87Dec 12, 25$13.36Dec 16, 25$12.77Dec 18, 25$13.60Dec 22, 25$13.29Dec 24, 25$12.76Dec 29, 25$12.25Jan 2, 26$12.42Jan 6, 26$13.32Jan 8, 26$13.36Jan 12, 26$14.06Jan 14, 26$12.85Jan 16, 26$12.15Jan 21, 26$11.66Jan 23, 26$11.92Jan 27, 26$11.77Jan 29, 26$10.82Feb 2, 26$10.92Feb 4, 26$11.02Feb 9, 26$10.35Feb 11, 26$9.23Feb 13, 26$8.75Feb 18, 26$8.38Feb 20, 26$8.20Feb 24, 26$7.64Feb 26, 26$7.84Mar 2, 26$7.39Mar 4, 26$7.87Mar 6, 26$6.74Mar 10, 26$6.58Mar 12, 26$5.93Mar 17, 26$6.62Mar 19, 26$6.15Mar 23, 26$6.43Mar 25, 26$7.18Mar 27, 26$6.60Mar 31, 26$6.28Apr 2, 26$6.56Apr 7, 26$6.65Apr 9, 26$6.16Apr 13, 26$5.93Apr 15, 26$6.40Apr 17, 26$7.17Apr 22, 26$6.80Apr 24, 26$6.43Apr 28, 26$6.40Apr 30, 26$6.23May 4, 26$6.77May 6, 26$6.47May 8, 26$6.44May 12, 26$6.34May 14, 26$5.18May 18, 26$5.09May 20, 26$4.97May 22, 26$4.94May 28, 26$5.10Jun 1, 26$5.38Jun 3, 26$4.95Jun 5, 26$5.11Jun 9, 26$5.07Jun 11, 26$5.28Jun 15, 26$5.32Jun 17, 26$5.08Jun 22, 26$4.68Jun 24, 26$4.74Jun 26, 26$5.12Jul 2, 26$6.19
$4.5452-week range$21.68
Loading valuation history…

Fundamentals

Key fundamentals

$98.8M

Market cap

18.8%

Revenue growth (YoY)

63.3%

Gross margin

$18.7M

Free cash flow (USD)

$2.7M

Net debt

1.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.8MFY 2017$12.1MFY 2018$21.2MFY 2019$24.6MFY 2020$43.3MFY 2021$61.3MFY 2022$62.5MFY 2023$71.5MFY 2024$92.1MFY 2025$109.4M
$7.8M$109.4M

Free cash flow by year

2016 → 2025

FY 2016$-815.5KFY 2017$-1.5MFY 2018$701.5KFY 2019$-3.2MFY 2020$-6.4MFY 2021$240.0KFY 2022$10.4MFY 2023$-8.1MFY 2024$4.8MFY 2025$18.7M
-$815.5K$18.7M

Gross margin by year

2021 → 2025

FY 202158.1%FY 202262.4%FY 202360.0%FY 202464.5%FY 202563.3%
58.1%63.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Plan AmendmentJun 12, 2026Filing
  • 8-K eventCCO DepartureJun 5, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventCredit Agreement ExecutedMay 12, 2026Filing
  • 8-K eventDirector AppointmentApr 9, 2026Filing

Questions

Frequently asked questions

What is OptimizeRx Corporation's market cap?

OptimizeRx Corporation (OPRX) has a market capitalization of $98.8M.

What is OPRX's P/E ratio?

OPRX trades at a price-to-earnings ratio of 19.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is OPRX's price-to-book (P/B) ratio?

OPRX trades at 0.77 times book value per share.

Are insiders buying OPRX stock?

SEC Form 4 filings show no open-market insider buys at OptimizeRx Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

CCLD

CareCloud, Inc.

$100.5M

DH

Definitive Healthcare Corp.

$94M

HCAT

Health Catalyst, Inc.

$104.6M

ONMD

OneMedNet Corporation

$41.5M

AMWL

American Well Corporation

$159.9M

EUDA

EUDA Health Holdings Limited

$34.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.